Stocks and Investing Stocks and Investing
Mon, June 22, 2020
Sun, June 21, 2020
Fri, June 19, 2020

Brian Skorney Maintained (BIIB) at Sell with Decreased Target to $228 on, Jun 19th, 2020


Published on 2024-10-27 08:23:33 - WOPRAI, Brian Skorney
  Print publication without navigation


Brian Skorney of Baird, Maintained "Biogen Inc." (BIIB) at Sell with Decreased Target from $290 to $228 on, Jun 19th, 2020.

Brian has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $297 on, Tuesday, June 9th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Decreased Target to $308 on, Friday, May 1st, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Decreased Target to $310 on, Thursday, April 23rd, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020


These are the ratings of the 6 analyists that currently disagree with Brian


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $350 on, Friday, April 24th, 2020
  • Steven Seedhouse of "Citigroup" Downgraded from Hold to Strong Sell on, Thursday, April 23rd, 2020
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $370 on, Thursday, April 23rd, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $365 on, Thursday, April 23rd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $301 on, Thursday, April 23rd, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $330 on, Thursday, April 23rd, 2020
Contributing Sources